Fig. 2: Baseline to day 90 ΔMELD score.
From: Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial
a, Box plot of ΔMELD score, split by treatment allocation. Control (CTRL) group: n = 24 participants. CELLS group: n = 27 participants (includes both single-infusion and triple-infusion participants). Box plots are defined as first to third quartile (Q1, Q3), with center line representing the median. Whiskers extend to the lowest/highest values no further than 1.5× IQR from Q1/Q3, as appropriate. b, Plot of total cell dose (n × 109) versus ΔMELD. Participants are color coded by dominant etiology (ALD, MASLD or Other). This plot includes all participants who received at least one infusion.
